Randomized, double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections.
Sixty-seven patients with complicated urinary tract infections were randomized in double-blind fashion to ceftazidime or moxalactam (MOX). A total of 54 patients were evaluable, 27 in each group. Patients received 500 mg of antibiotic intravenously every 12 h, except for those with Pseudomonas aerug...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
1985
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180235/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3914859/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.28.2.299 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
